ObjectiveTo describe the use patterns, impact and derived patient-user value of a mobile web-based virtual triage/symptom checker.MethodsOnline survey of 2,113 web-based patient-users of a virtual triage/symptom checker was completed over an 8-week period. Questions focused on triage and care objectives, pre- and post-triage care intent, frequency of use, value derived and satisfaction with virtual triage. Responses were analyzed and stratified to characterize patient-user pre-triage and post-triage intent relative to triage engine output.ResultsSeventy-eight percent of virtual triage users were female, and 37% were 18–24 years old or younger, 28% were 25–44, 16% were 45–54, and 19% were 55 years or older; 41.2% completed the survey from the U.S., 12.5% from the U.K., 9.1% from Canada, 5.6% from India, 3.8% from South Africa. Motivations were to determine need to consult a physician (44.2%), to secure medical advice without visiting a physician (21.0%), and to confirm a diagnosis received (14.2%). Forty-three percent were first time users of virtual triage, 36.6% utilized a triage engine at least once every few months or more often. Pre-triage, 40.5% did not know what level of healthcare they were planning to utilize, 33.9% stated they intended to seek a physician consultation, 23.7% engage self-care and 1.8% seek emergency care. Virtual triage recommended 56.8% of patient-users consult a physician, 33.8% seek emergency care and 9.4% engage self-care. In three-fourths, virtual triage helped users decide level of care to pursue. Among 74.1%, triage recommended care different than pre-triage intentions. Post-triage, those who remained uncertain of their care path decreased by 25.4%. Patient-user experience and satisfaction with virtual triage was high, with 80.1% stating that they were highly likely or likely to use it again, and interest in and willingness to use telemedicine doubled.ConclusionVirtual triage successfully redirected patient-users who initially planned to seek an inappropriate level of care acuity, reduced patient uncertainty of care path, and doubled the percentage of patients amenable to telemedicine and virtual health engagement. Patient-users were highly satisfied with virtual triage and the virtual triage patient experience, and a large majority will use virtual triage recurrently in the future.

BACKGROUND (-) OBJECTIVE COVID-19 pandemic has sped up the implementation of telehealth solutions in medicine. This paper demonstrates our experiences with the COVID-19 Risk Assessment Tool. We tried to determine who is the user of the web-based COVID-19 triage application and compare this group with the patients of the infectious diseases ward’s admission room to evaluate who could benefit from implementing the COVID-19 online symptom checker as a remote triage solution. METHODS We have analyzed the answers of more than 650 000 people interacting with an online WHO-based triage tool for assessing the probability of SARS-CoV-2 infection. Based on the presented symptoms, risk factors, and demographics, the tool has assessed if the user’s answers are suggestive of COVID-19 and recommended appropriate action. Subsequently, we have compared “patient profiles” of tool users with patients admitting to the Infectious Diseases Admission Room. RESULTS COVID-19 Risk Assessment tool tended to be used by asymptomatic or oligosymptomatic individuals, which constituted 70.58% of all users. The majority of users were young (67.30% were below 40 years of age) and without significant comorbidities. On the contrary, most admission room patients were symptomatic - symptoms like fever, cough and dyspnea were prevalent in both covid positive and negative patients. COVID-suspected patients in the self-assessment tool presented similar COVID-19 symptoms as those who presented to the admission room. These were: cough (66.51% in self-assessment tool, 59.48% in the admission room, P=.03), fever (57.79% in the self-assessment tool, 62,93% in the admission room, P=.13), and shortness of breath (8.73% in the self-assessment tool vs. 37.50% in the admission room, P<.001). CONCLUSIONS The self-assessment COVID-19 tool, as it served as the means of screening and self-education, did not substitute for the consultation in the admission room for symptomatic patients. It seems that these types of solutions may serve as health information hubs for oligosymptomatic individuals, as well as a way of identifying and advising patients at risk. It fulfils the idea of remote, pre-clinical triage, however, the accuracy and influence on healthcare must be examined in the clinical setting.

developing therapeutic human antibodies, and financial interest in TenSixteen Bio, a company targeting somatic mosaicism and clonal hematopoiesis of indeterminate potential to discover and develop novel therapeutics to treat age-related diseases, and in Soley Therapeutics, a biotechnology company that is combining artificial intelligence with molecular and cellular response detection for discovering and developing new drugs, currently focusing on cancer therapeutics. Dr Bhatt reported receiving grants from Amarin, Amgen, Novartis, and Sanofi outside the submitted work; serving on an advisory board for Angiowave, Bayer,

Background The COVID-19 pandemic has sped up the implementation of telehealth solutions in medicine. A few symptom checkers dedicated for COVID-19 have been described, but it remains unclear whether and how they can affect patients and health systems. Objective This paper demonstrates our experiences with the COVID-19 risk assessment (CRA) tool. We tried to determine who the user of the web-based COVID-19 triage app is and compare this group with patients in the infectious diseases ward’s admission room to evaluate who could benefit from implementing the COVID-19 online symptom checker as a remote triage solution. Methods We analyzed the answers of 248,862 people interacting with an online World Health Organization–based triage tool for assessing the probability of SARS-CoV-2 infection. These users filled in an online questionnaire between April 7 and August 6, 2020. Based on the presented symptoms, risk factors, and demographics, the tool assessed whether the user’s answers were suggestive of COVID-19 and recommended appropriate action. Subsequently, we compared the sociodemographic and clinical characteristics of tool users with patients admitted to the Infectious Diseases Admission Room of J. Gromkowski Hospital in Wrocław. Results The CRA tool tended to be used by asymptomatic or oligosymptomatic individuals (171,226 [68.80%] of all users). Most users were young (162,432 [65.27%] were below 40 years of age) and without comorbidities. Only 77,645 (31.20%) of the self-assessment app users were suspected of COVID-19 based on their reported symptoms. On the contrary, most admission room patients were symptomatic—symptoms such as fever, cough, and dyspnea were prevalent in both COVID-19-positive and COVID-19-negative patients. COVID-19-suspected patients in the CRA tool group presented similar COVID-19 symptoms as those who presented to the admission room. These were cough (25,062/40,007 [62.64%] in the CRA tool group vs 138/232 [59.48%] in the admission room group), fever (23,123/40,007 [57.80%] in the CRA tool group vs 146/232 [62.93%] in the admission room group), and shortness of breath (15,157/40,007 [37.89%] in the CRA tool group vs 87/232 [37.50%] in the admission room group). Conclusions The comparison between the symptomatology of the users interacting with the CRA tool and those visiting the admission room revealed 2 major patient groups who could have benefited from the implementation of the self-assessment app in preclinical triage settings. The primary users of the CRA tool were young, oligosymptomatic individuals looking for screening for COVID-19 and reassurance early in the COVID-19 pandemic. The other group were users presenting the typical symptoms suggestive of COVID-19 at that time. The CRA tool recognized these individuals as potentially COVID-19 positive and directed them to the proper level of care. These use cases fulfil the idea of preclinical triage; however...